About MitoMetabLab
MitoMetabLab is an academic mitochondrial biology research laboratory at Queen's University in Kingston, Ontario, Canada. Directed by a Tier II Canada Research Chair and supported by the Canada Foundation for Innovation - John Evans Leaders Fund, we are focused on the cellular and molecular mechanisms of metabolic and cardiovascular diseases. Our mission is to determine how mitochondrial structure, function, and genetics contribute to physiology and pathology.
Latest News
October 6th, 2022
AWARD ALERT! Please join Dr. Dunham-Snary and Team MitoMetabLab in celebrating Travel/Abstract awards for Mia and Abhishek! Both Mia and Abhi were amongst the highest scoring abstracts for the Society for Redox Biology & Medicine's Annual Conference, and will travel with Dr. D-S to Orlando in November to present their work. Everyone is excited for our first in-person conference since 2019!
SfRBM Travel Awards Announcement: https://sfrbm.org/meetings/2022-annual-conference/2022-trainee-awards/
September 6th, 2022
MitoMetabLab has been celebrating its 2nd birthday this past week, and wow how we have grown! Dr. Dunham-Snary is delighted to welcome returning scholars Mia and Abhi (TMED MSc), Dalia (LISC 595 - Mitochondrial Biology), and Samsara (work study research scholar) and extend a warm welcome to new members of Team MitoMetabLab: Justin (DBMS-EM MSc) joins the team from WesternU; Jennifer (PATH 499) and Cassandra (PHGY 499) will be completing their honours theses this year, and Raymond (BHSc-Yr 3) will complete the research portion of his health sciences degree.
The "new normal" will take some adjusting, and we will continue to operate at full capacity, observing best practices as the pandemic is not yet over, but the team is excited to get to work!
June 28th, 2022
FUNDING ALERT! Dr. Dunham-Snary and MitoMetabLab have been awarded the Banting-Mitacs 2022 Discovery Award. This award will support expansion of the lab's ongoing mito-'omic fingerprinting project. We wish to extend our gratitude to the Banting Research Foundation and Mitacs Canada for their research support.
Dr. Dunham-Snary has dedicated this award to the memory her dear friend, and former colleague, David G Westbrook Jr.
BRF Press Release: https://www.bantingresearchfoundation.ca/2022-discovery-award-winners/
June 23rd, 2022
GRADUATION ALERT! Dr. Dunham-Snary and Team MitoMetabLab are celebrating their first graduates! Congratulations Mia and Abhishek! We are looking forward to your next steps as MitoMetabLab's first MSc students!
January 12th, 2022
IMPORTANT ANNOUNCEMENT & FUNDING ALERT! Dr. Dunham-Snary has been named a Tier II Canada Research in 'Mitochondrial and Metabolic Regulation in Health and Disease'. Additionally, MitoMetabLab has been awarded substantial infrastructure funding from the CFI-John Evans Leaders Fund, which will support procurement of cutting-edge equipment. We would like to thank Queen's University for their continued support and will continue to pursue our research mission with integrity and curiosity.
CRC Press Release: https://www.chairs-chaires.gc.ca/whats_new-quoi_de_neuf/2022/crc-2020-2-eng.aspx
CFI Press Release: https://www.innovation.ca/news/jelf-crc-jan-2022
Media
Dr. Dunham-Snary presents 'Mitochondrial-Nuclear Genetic Interaction in Health and Disease' as a keynote speaker at York University's 11th Muscle Health Awareness Day.
Queen's CardioPulmonary Unit (QCPU): established with funding from the Canada Foundation for Innovation, QCPU is home to translational research in heart, lung, blood, and vascular diseases.